Zinc Gel and Epidermal Regeneration in Healthy Human Volunteers
NCT ID: NCT02116725
Last Updated: 2014-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
30 participants
INTERVENTIONAL
2014-03-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of our study is to see whether repeated washing with zinc containing shower gel of superficial wounds will result in increased healing.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Wound Healing, Cooling Efficacy and Local Tolerability of a Wound Care Hydrogel
NCT06309446
Clinical Utility of a New Silver Gel for Use on Chronic Wounds
NCT01442103
Plasma on Chronic Wounds for Epidermal Regeneration
NCT05855499
Clinical Trial To Study The Anti-scarring Effect Of Cicatricell
NCT03020420
Comparison of the Effect of Vaseline and Bepanthen® "Wund- Und Heilsalbe" on the Wound Healing Following Laser Therapy
NCT03095872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In 30 healthy volunteers one epidermal wound (10 mm in diameter) is induced by suction and heat on each buttock. The wounds are washed with shower gel containing zinc, placebo shower gel or water (reference). The treatments are allocated by randomization ensuring that 20 wounds are washed with shower gel containing zinc, 20 wounds are washed with placebo shower gel and 20 wounds are washed with water.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Shower gel with zinc
Zinc gel is applied daily (50 µl/cm2) to wound and surrounding noninjured skin.
Shower gel with zinc
Standard shower gel (Sanex) supplemented with zinc sulfate.
Plain shower gel
Plain shower gel is applied daily (50 µl/cm2) to wound and surrounding noninjured skin.
Plain shower gel
Standard shower gel (Sanex).
Distilled water
Distilled Water is applied daily (50 µl/cm2) to wound and surrounding noninjured skin.
Distilled water
Sterile distilled Water.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Shower gel with zinc
Standard shower gel (Sanex) supplemented with zinc sulfate.
Plain shower gel
Standard shower gel (Sanex).
Distilled water
Sterile distilled Water.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between18 and 65 years
* Written informed consent
Exclusion Criteria
* Active skin disease in test areas
* Hypersensitivity to zinc or any of the shower gel ingredients
* Immunosuppressive treatment
* Pregnant or breastfeeding females
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lars Nannestad Jorgensen
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Digestive Disease Center and Copenhagen Wound Healing Center, University of Copenhagen
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Heidi F Larsen, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Agren MS. Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen. 2007 Jan-Feb;15(1):2-16. doi: 10.1111/j.1524-475X.2006.00179.x.
Woodley DT, Kim YH. A double-blind comparison of adhesive bandages with the use of uniform suction blister wounds. Arch Dermatol. 1992 Oct;128(10):1354-7.
Agren MS, Mirastschijski U, Karlsmark T, Saarialho-Kere UK. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp Dermatol. 2001 Oct;10(5):337-48. doi: 10.1034/j.1600-0625.2001.100506.x.
Malminen M, Koivukangas V, Peltonen J, Karvonen SL, Oikarinen A, Peltonen S. Immunohistological distribution of the tight junction components ZO-1 and occludin in regenerating human epidermis. Br J Dermatol. 2003 Aug;149(2):255-60. doi: 10.1046/j.1365-2133.2003.05438.x.
Agren MS, Chvapil M, Franzen L. Enhancement of re-epithelialization with topical zinc oxide in porcine partial-thickness wounds. J Surg Res. 1991 Feb;50(2):101-5. doi: 10.1016/0022-4804(91)90230-j.
Ferraq Y, Black DR, Theunis J, Mordon S. Superficial wounding model for epidermal barrier repair studies: comparison of Erbium:YAG laser and the suction blister method. Lasers Surg Med. 2012 Sep;44(7):525-32. doi: 10.1002/lsm.22054. Epub 2012 Aug 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERS-2013-01-LDT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.